The center will be located within RIKEN’s Integrated Innovation Institute in Kobe. RIKEN’s partner is Takashi TSUJI, a RIKEN specialist on 3D cell manipulations leading to organ structures, and Meiji Seika Pharma will start by contributing Meiji collagenase G and H for cell separation

Meiji Seika Pharma news release, March 16, 2016